Therefore, FOXO3 acetylation, regulated coordinately by EP300 and sirtuins, is an important PTM which regulates FOXO3 expression and transcriptional activity to modulate lapatinib sensitivity in breast cancer (Supplementary Figure S6). Here, FOXO3 is linked to breast carcinoma.